All Posts tagged 'Bexsero'

December 11, 2013

News & Notes: In midst of meningitis outbreak, UCSB parents demand access to vaccine

As the emergency meningitis vaccine campaign at the University enters its fourth day with 4,361 students and select community members vaccinated, the parents of students at the University of California, Santa Barbara want their children to receive the vaccine as well, NBC News reported. Four students at UCSB have … Read More

December 9, 2013

Almost 2000 receive vaccination in first day of campaign

1,959 students were vaccinated against meningococcal-B on the first day of the vaccination campaign, according to University Spokesperson Martin Mbugua. As of 4:30 p.m., the number was 1,261. There was a small number of students who experienced adverse effects, although these effects were within expected ranges. The vaccination campaign began … Read More

November 26, 2013

Updated: CDC approves meningitis vaccination campaign; dates announced

The Centers for Disease Control and Prevention has given final approval for a meningitis vaccination campaign to commence at Princeton, the University announced in an email last week. The vaccine will be made available to all undergraduate students, graduate students living in undergraduate dormitories, the Graduate College and annexes and other … Read More

November 25, 2013

Importation of Novartis meningitis vaccine not likely to make U. liable

Princeton’s plan to make a meningitis vaccine — called Bexsero — available to students in the near future likely has few legal ramifications for the University, despite the fact that the U.S. Food and Drug Administration has not yet approved the drug for use in the United States. Since March, … Read More

November 20, 2013

76 percent of students say they plan to get meningitis vaccine

Out of a total of 259 students interviewed by The Daily Princetonian between Tuesday and Wednesday, 197, or 76 percent, said they plan to get a vaccine not yet licensed in the United States that will be offered by the University to combat a campus outbreak of type B … Read More

November 19, 2013

Vaccine manufacturer Novartis likely not to benefit from emergency deal with Princeton

The commercial success of Bexsero — the vaccine made by Swiss pharmaceutical company Novartis that will be offered to Princeton students in December and is not yet licensed for use in the United States — is crucial for the future of the company’s vaccine department, according to a … Read More

November 15, 2013

Updated: Princeton expected to make decision on unapproved meningitis vaccine Monday

The University is expected to announce Monday whether it will allow the Centers for Disease Control and Prevention to offer a meningitis vaccine not yet approved for use in the United States to the Princeton community. Seven University-associated individuals have been hospitalized with the disease since March. In the face of … Read More